AIM

Actualités AIM ImmunoTech

Nom Action Symbole Action Marché Type
AIM ImmunoTech Inc AIM AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,0% 0,3807 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,3807
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/12/202214:05GLOBEAIM ImmunoTech Reports Positive Safety, Tolerability and..
02/12/202216:45GLOBEAIM ImmunoTech Announces Abstract Accepted for Poster..
15/11/202213:00GLOBEAIM ImmunoTech Reports Third Quarter 2022 Financial Results..
14/11/202223:02EDGARAmended Securities Registration (section 12(b)) (8-a12b/a)
14/11/202222:54EDGARQuarterly Report (10-q)
14/11/202213:00GLOBEAIM ImmunoTech Announces Presentation of New Data from..
09/11/202215:00BWAIM ImmunoTech Announces Corporate Governance Enhancements
03/11/202217:34BWAIM ImmunoTech Shareholders Elect All Three Company Director..
02/11/202212:05GLOBEAIM ImmunoTech Receives Orphan Drug Designation for Ampligen..
01/11/202222:19GLOBEStatement of the ASFV Committee on Ruling in Delaware Action
31/10/202213:56EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
31/10/202212:30BWDelaware Court Rules in Favor of AIM ImmunoTech and Declines..
26/10/202223:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
26/10/202223:12BWAIM ImmunoTech Board Issues Letter to Shareholders
24/10/202214:30GLOBEASFV Committee Reveals Troubling Statements Made by..
13/10/202222:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
13/10/202220:36EDGARAdditional Proxy Soliciting Materials - Non-management..
13/10/202216:32GLOBEU.S. District Court Dismisses AIM’s "Baseless" Section 13(d)..
12/10/202223:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/10/202214:45GLOBEAIM ImmunoTech Announces FDA Clearance of IND Application to..
28/9/202223:16EDGARAdditional Proxy Soliciting Materials - Non-management..
26/9/202222:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
21/9/202223:20EDGARRevised Proxy Soliciting Materials (definitive) (defr14a)
21/9/202214:45GLOBEAIM ImmunoTech to Present at the Virtual Investor Long COVID..
20/9/202212:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
19/9/202214:05BWAIM ImmunoTech Board Files Definitive Proxy Statement and..
19/9/202214:01EDGARProxy Statment - Contested Solicitations (definitive)..
15/9/202214:52EDGARProxy Statement - Contested Solicitations (preliminary)..
13/9/202222:05EDGARInitial Statement of Beneficial Ownership (3)
09/9/202222:16EDGARCurrent Report Filing (8-k)
07/9/202213:25GLOBEAIM ImmunoTech to Present at the H.C. Wainwright 24th Annual..
06/9/202213:30GLOBEAIM ImmunoTech Selected to Present at the 2nd Annual Marie..
30/8/202213:30GLOBEAIM ImmunoTech and Study Collaborator Roswell Park Commence..
18/8/202215:05GLOBEAIM ImmunoTech Announces Commencement of Phase 2 Study of..
16/8/202222:05GLOBEAIM Stockholder Full Value Committee Reiterates Intent to..
15/8/202222:57EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
15/8/202222:05BWAIM ImmunoTech Provides Update on Jorgl Activist Group..
15/8/202214:05EDGARQuarterly Report (10-q)
15/8/202214:05GLOBEAIM ImmunoTech Reports Second Quarter 2022 Financial Results..
28/7/202215:10GLOBEAIM ImmunoTech Reports Positive Pilot Study Data from..
20/7/202214:05GLOBEAIM ImmunoTech reports additional patient data from..
18/7/202221:02EDGARStatement of Changes in Beneficial Ownership (4)
18/7/202214:00GLOBEAIM ImmunoTech Announces that Recently Received Director..
14/7/202214:05GLOBEAIM ImmunoTech to Present at the Virtual Investor..
01/7/202222:32EDGARSecurities Registration: Employee Benefit Plan (s-8)
21/6/202214:35GLOBEAIM ImmunoTech Secures New State-of-the-Art Facility for..
17/6/202215:01EDGARCurrent Report Filing (8-k)
13/6/202214:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Portfolio for..
19/5/202214:00GLOBEAIM ImmunoTech to Present at the H.C. Wainwright Global..
18/5/202214:00GLOBEAIM ImmunoTech Provides Update on Ampligen Long COVID..
Dernières Valeurs Consultées
AMEX
AIM
AIM Immuno..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20221209 08:43:55